Hepatitis Monthly

Published by: Kowsar

Update on Transmission Modes of Hepatitis C Virus Among Volunteer Iranian Blood Donors: Analysis of a Matched Case-Control Study by Penalized Conditional Logistic Regression

Fahimeh Ranjbar Kermani 1 , Kamran Mousavi Hosseini 1 , * , Sedigheh Amini Kafi-abad 1 , Mahtab Maghsudlu 1 , Zohreh Sharifi 1 , Mohammad Ali Mansournia 2 and Seyed Moayed Alavian 3 , 4
Authors Information
1 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
2 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
3 Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, Iran
4 Middle East Liver Diseases (MELD) Center, Tehran, Iran
Article information
  • Hepatitis Monthly: October 2018, 18 (10); e69395
  • Published Online: October 13, 2018
  • Article Type: Research Article
  • Received: April 14, 2018
  • Revised: September 2, 2018
  • Accepted: September 16, 2018
  • DOI: 10.5812/hepatmon.69395

To Cite: Ranjbar Kermani F, Mousavi Hosseini K, Amini Kafi-abad S, Maghsudlu M, Sharifi Z, et al. Update on Transmission Modes of Hepatitis C Virus Among Volunteer Iranian Blood Donors: Analysis of a Matched Case-Control Study by Penalized Conditional Logistic Regression, Hepat Mon. 2018 ; 18(10):e69395. doi: 10.5812/hepatmon.69395.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnote
References
  • 1. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17(2):107-15. doi: 10.1111/j.1469-0691.2010.03432.x. [PubMed: 21091831].
  • 2. Cooke GS, Lemoine M, Thursz M, Gore C, Swan T, Kamarulzaman A, et al. Viral hepatitis and the Global Burden of Disease: A need to regroup. J Viral Hepat. 2013;20(9):600-1. doi: 10.1111/jvh.12123. [PubMed: 23910643].
  • 3. Lanini S, Easterbrook PJ, Zumla A, Ippolito G. Hepatitis C: /Global epidemiology and strategies for control. Clin Microbiol Infect. 2016;22(10):833-8. doi: 10.1016/j.cmi.2016.07.035. [PubMed: 27521803].
  • 4. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45-57. doi: 10.1016/j.jhep.2014.07.027. [PubMed: 25086286].
  • 5. Mirminachi B, Mohammadi Z, Merat S, Neishabouri A, Sharifi AH, Alavian SH, et al. Update on the prevalence of hepatitis C virus infection among Iranian general population: A systematic review and meta-analysis. Hepat Mon. 2017;17(2). doi: 10.5812/hepatmon.42291.
  • 6. World Health Organization. Blood safety and availability. WHO fact sheet. WHO; 2016. Available from: http://www.who.int/news-room/fact-sheets/detail/blood-safety-and-availability.
  • 7. Amini Kafi-Abad S. Blood safety overview in Iran. Arch Iran Med. 2015;18(10).
  • 8. World Health Organization. Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. Geneva, Switzerland: WHO; 2016.
  • 9. Liakina V, Hamid S, Tanaka J, Olafsson S, Sharara AI, Alavian SM, et al. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3. J Viral Hepat. 2015;22 Suppl 4:4-20. doi: 10.1111/jvh.12475. [PubMed: 26513445].
  • 10. European Association for Study of Liver. EASL clinical practice guidelines: Management of hepatitis C virus infection. J Hepatol. 2014;60(2):392-420. doi: 10.1016/j.jhep.2013.11.003. [PubMed: 24331294].
  • 11. Leparc GF. Safety of the blood supply. Cancer Control. 2015;22(1):7-15. doi: 10.1177/107327481502200103. [PubMed: 25504274].
  • 12. World Health Organization. Blood donor selection: Guidelines on assessing donor suitability for blood donation. Geneva: WHO; 2012.
  • 13. Maghsudlu M. Keys to move to self-sufficiency in safe blood components based on voluntary blood donation. ISBT Sci Serie. 2017;12(1):202-6. doi: 10.1111/voxs.12344.
  • 14. Birjandi F, Gharehbaghian A, Delavari A, Rezaie N, Maghsudlu M. Blood donor deferral pattern in Iran. Arch Iran Med. 2013;16(11):657-60. [PubMed: 24206408].
  • 15. Polaris Observatory H C V Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study. Lancet Gastroenterol Hepatol. 2017;2(3):161-76. doi: 10.1016/S2468-1253(16)30181-9. [PubMed: 28404132].
  • 16. Alavian SM, Hajarizadeh B, Bagheri Lankarani K, Sharafi H, Ebrahimi Daryani N, Merat S, et al. Recommendations for the clinical management of hepatitis C in Iran: A consensus-based national guideline. Hepat Mon. 2016;16(8). e40959. doi: 10.5812/hepatmon.guideline. [PubMed: 27799966]. [PubMed Central: PMC5075356].
  • 17. Alavian SM, Hatami S. [The evaluation of acute viral hepatitis patients referred to tehran hepatitis center with regard to etiology and risk factors (2000-2001)]. Govaresh J. 2016;6(33-34):125-30. Persian.
  • 18. Rezaei N, Amini-Kafiabad S, Maghsudlu M, Abolghasemi H. Risk factor analysis of hepatitis C virus seropositivity in Iranian blood donors: A case-control study. Transfusion. 2016;56(7):1891-8. doi: 10.1111/trf.13660. [PubMed: 27273657].
  • 19. Huang Y, Guo N, Yu Q, Lv Y, Ma H, Yun Z, et al. Risk factors for hepatitis B and C infection among blood donors in five Chinese blood centers. Transfusion. 2015;55(2):388-94. doi: 10.1111/trf.12850. [PubMed: 25382751].
  • 20. Custer B, Kessler D, Vahidnia F, Leparc G, Krysztof DE, Shaz B, et al. Risk factors for retrovirus and hepatitis virus infections in accepted blood donors. Transfusion. 2015;55(5):1098-107. doi: 10.1111/trf.12951. [PubMed: 25470984]. [PubMed Central: PMC4428964].
  • 21. Mitrovic N, Delic D, Markovic-Denic L, Jovicic M, Popovic N, Bojovic K, et al. Seroprevalence and risk factors for hepatitis C virus infection among blood donors in Serbia: A multicentre study. Dig Liver Dis. 2015;47(7):572-6. doi: 10.1016/j.dld.2015.03.019. [PubMed: 25882212].
  • 22. Czerwinski M, Grabarczyk P, Stepien M, Kubicka-Russel D, Tkaczuk K, Brojer E, et al. What weighs more-low compliance with self-deferral or minor medical procedures? Explaining the high rate of hepatitis C virus window-period donations in Poland. Transfusion. 2017;57(8):1998-2006. doi: 10.1111/trf.14163. [PubMed: 28555775]. [PubMed Central: PMC5703057].
  • 23. Khan ZA, Shafiq M, Shahab F. Frequency and risk factors of hepatitis b and c in Afghan patients presenting to Tertiary Care Hospital in Peshawar. Pakistan Arm Forc Med J. 2015;(5):686.
  • 24. Hussein NR, Saleem ZSM. An outbreak of hepatitis C virus at a renal dialysis unit: A lesson from a war zone. Int J Infect. 2016;In Press(In Press). doi: 10.17795/iji-39763.
  • 25. Sharma S, Sharma AK, Sujatha R, Bansal A. Risk factors of hepatitis C infection in patients of chronic liver disease in a rural area of Uttar Pradesh. India J Sci Res. 2016;7(1):193.
  • 26. Arshad A, Ashfaq UA. Epidemiology of hepatitis C infection in pakistan: Current estimate and major risk factors. Crit Rev Eukaryot Gene Expr. 2017;27(1):63-77. doi: 10.1615/CritRevEukaryotGeneExpr.2017018953. [PubMed: 28436333].
  • 27. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: A case-control study. J Gastroenterol Hepatol. 2002;17(10):1092-7. doi: 10.1046/j.1440-1746.2002.02843.x. [PubMed: 12201870].
  • 28. Hajiani E, Hashemi J, Masjedizadeh R, Shayesteh AA, Idani E, Rajabi T. Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: A case-control study. World J Gastroenterol. 2006;12(30):4884-7. doi: 10.3748/wjg.12.4884. [PubMed: 16937474]. [PubMed Central: PMC4087626].
  • 29. Vossoughinia H, Taghi Shakeri M, Mokhtari Amirmajdi E, Abedini S. [Risk factors for hepatitis B and C in 400 blood donor volunteers in Mashhad During 2003-2007: A case-control study]. Horizon Med Sci. 2010;15(4):68-75. Persian.
  • 30. Alavian SM. Hepatitis C virus infection: Epidemiology, risk factors and prevention strategies in public health in IR IRAN. Gastroenterol Hepatol bed bench. 2009;3(1).
  • 31. Greenland S, Mansournia MA. Penalization, bias reduction, and default priors in logistic and related categorical and survival regressions. Stat Med. 2015;34(23):3133-43. doi: 10.1002/sim.6537. [PubMed: 26011599].
  • 32. Greenland S, Mansournia MA, Altman DG. Sparse data bias: A problem hiding in plain sight. BMJ. 2016;352. i1981. doi: 10.1136/bmj.i1981. [PubMed: 27121591].
  • 33. Mansournia MA, Geroldinger A, Greenland S, Heinze G. Separation in logistic regression: Causes, consequences, and control. Am J Epidemiol. 2018;187(4):864-70. doi: 10.1093/aje/kwx299. [PubMed: 29020135].
  • 34. Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, et al. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI retrovirus epidemiology donor study (REDS). Hepatology. 2000;31(3):756-62. doi: 10.1002/hep.510310329. [PubMed: 10706569].
  • 35. O'Brien SF, Fan W, Xi G, Yi QL, Goldman M, Fearon MA, et al. Declining hepatitis C rates in first-time blood donors: Insight from surveillance and case-control risk factor studies. Transfusion. 2008;48(5):902-9. doi: 10.1111/j.1537-2995.2007.01618.x. [PubMed: 18208409].
  • 36. Brandao AB, Fuchs SC. Risk factors for hepatitis C virus infection among blood donors in southern Brazil: A case-control study. BMC Gastroenterol. 2002;2:18. doi: 10.1186/1471-230X-2-18. [PubMed: 12169200]. [PubMed Central: PMC122085].
  • 37. Woltmann J, Burke P, Brady R, Blackard JT. Demographics of hepatitis C in Southwest Ohio (2010 to 2015). Hepat Mon. 2016;16(8). e37904. doi: 10.5812/hepatmon.37904. [PubMed: 27799964]. [PubMed Central: PMC5075223].
  • 38. Orton SL, Stramer SL, Dodd RY, Alter MJ. Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti‐HCV. Transfus. 2004;44(2):275-81. doi: 10.1111/j.1537-2995.2004.00623.x. [PubMed: 14962320].
  • 39. Al-Waleedi AA, Khader YS. Prevalence of hepatitis B and C infections and associated factors among blood donors in Aden City, Yemen. East Mediterr Health J. 2012;18(6):624-9. [PubMed: 22888620].
  • 40. Terrault NA, Dodge JL, Murphy EL, Tavis JE, Kiss A, Levin TR, et al. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: The HCV partners study. Hepatology. 2013;57(3):881-9. doi: 10.1002/hep.26164. [PubMed: 23175457]. [PubMed Central: PMC4384338].
  • 41. Zobeiri M, Adibi P, Alavian SM. Intravenous drug use and hepatitis C virus in iran. Hepat Mon. 2012;12(1):9-10. doi: 10.5812/kowsar.1735143X.797. [PubMed: 22451838]. [PubMed Central: PMC3298870].
  • 42. Taherkhani R, Farshadpour F. Epidemiology of hepatitis C virus in Iran. World J Gastroenterol. 2015;21(38):10790-810. doi: 10.3748/wjg.v21.i38.10790. [PubMed: 26478671]. [PubMed Central: PMC4600581].
  • 43. Khodadost M, Maajani K, Arabsalmani M, Mahdavi N, Tabrizi R, Alavian SM, et al. Is tattooing a risk factor for hepatitis c transmission?: An updated systematic review and meta-analysis. hepat Mon. 2017;17(9). doi: 10.5812/hepatmon.14308.
  • 44. Madani TA. Hepatitis C virus infections reported in Saudi Arabia over 11 years of surveillance. Ann Saudi Med. 2007;27(3):191-4. doi: 10.5144/0256-4947.2007.191. [PubMed: 17568177]. [PubMed Central: PMC6077082].
  • 45. Chandra M, Khaja MN, Farees N, Poduri CD, Hussain MM, Aejaz Habeeb M, et al. Prevalence, risk factors and genotype distribution of HCV and HBV infection in the tribal population: A community based study in south India. Trop Gastroenterol. 2003;24(4):193-5. [PubMed: 15164530].
  • 46. Tanwandee T, Piratvisuth T, Phornphutkul K, Mairiang P, Permpikul P, Poovorawan Y. Risk factors of hepatitis C virus infection in blood donors in Thailand: A multicenter case-control study. J Med Assoc Thai. 2006;89 Suppl 5:S79-83. [PubMed: 17722300].
  • 47. Dahiya P, Kamal R, Sharma V, Kaur S. "Hepatitis" - Prevention and management in dental practice. J Educ Health Promot. 2015;4:33. doi: 10.4103/2277-9531.157188. [PubMed: 26097847]. [PubMed Central: PMC4456879].
  • 48. Mahboobi N, Porter SR, Karayiannis P, Alavian SM. Dental treatment as a risk factor for hepatitis B and C viral infection. A review of the recent literature. J Gastrointestin Liver Dis. 2013;22(1):79-86. [PubMed: 23539395].
  • 49. Al-Kubaisy MW, Bobryshev YV, Shamsidah Ni N, Al-Naggar RA, Al-Kubaisy W. Is dental extraction a risk factor for contracting HCV infection: Abs, RNA and genotype detection. Oral Biol Dentistr. 2014;2(1):7. doi: 10.7243/2053-5775-2-7.
  • 50. Abdulla EM, Abdulla FE. Seropositive HBSAG frequency in Karachi and interior Sindh, Pakistan. Pak J Med Sci. 2007;23(2):157-60.
  • 51. Sharhani A, Mehrabi Y, Noroozi A, Nasirian M, Higgs P, Hajebi A, et al. Hepatitis C Virus seroprevalence and associated risk factors among male drug injectors in Kermanshah, Iran. Hepat Mon. 2017;17(10). doi: 10.5812/hepatmon.58739.
  • 52. Razjou F, Maghsudlu M, Nasizadeh S, Zadsar M. The impact of donor selection on blood safety in Iran. Transfus Apher Sci. 2012;47(1):13-6. doi: 10.1016/j.transci.2012.03.001. [PubMed: 22521567].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments